{"nct_id":"NCT01732926","title":"Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas","status":"TERMINATED","status_verified_date":"2017-03","start_date":"2013-01-02","start_date_type":"ACTUAL","primary_completion_date":"2016-05-17","primary_completion_date_type":"ACTUAL","completion_date":"2016-05-17","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}